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induced apoptosis for example of endothelial cells or bone mar-
row stem cells is clinically relevant as initiating step for normal
tissue damage after radiotherapy.
We have established several gene-therapeutic approaches to
suppress radiation induced apoptosis by overexpression of
super-oxide dismutase (SOD) and P-glycoprotein (P-gp) the prod-
uct of the multi-drug resistance gene (MDR). Clonogenic assays
showed that radioresistance can be induced in normal tissue
cells (e.g. human primary lung fibroblasts), whereas the survival
of human tumor cells (e.g. HeLa) after radiotherapy is not
altered. Using differential gene expression analysis and quanti-
tative real-time PCR, we showed up-regulation of detoxification
genes and down-regulation of pro-apoptotic genes (e.g. CASP1,
CASP4).
Targeting the apoptotic pathway to induce radioresistance in
normal tissue cells is a potential strategy to increase the thera-
peutic index in radiation oncology.
doi:10.1016/j.ejcsup.2006.04.042
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Twenty to twenty-five percent of all cases of colorectal cancer
(CRC) show some familiarity. Although the role of genes is not
yet completely understood, a number of well-defined genetic dis-
ease entities is known to contribute to the familiarity: Lynch syn-
drome (formerly hereditary nonpolyposis colorectal cancer,
HNPCC), familial adenomatous polyposis (FAP), MYH-associated
polyposis (MAP), juvenile polyposis, Peutz–Jeghers syndrome.
The most common genetic form of CRC is Lynch syndrome that
is responsible for 2–3% of all cases. The analysis of these diseases
led to valuable insights into the disease process also of the spo-
radic forms of CRC.
We need a filter system within the public health care system
that allows the detection of families with an increased genetic
risk. Individuals belonging to such families should first undergo
genetic counselling. Genetic analysis can largely differentiate
between the risks. Persons at increased risk should be included
in a risk-adapted screening programme. Only specialized centers
for inherited CRC will be able to efficiently organize programs of
CRC prevention.
The ongoing collaborative study of the German Cancer Aid will
give clear data as to the efficacy of systematic cancer prevention
in Lynch syndrome through early detection, particularly through
colonoscopy and gynecological examinations.
doi:10.1016/j.ejcsup.2006.04.043
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Hereditary colorectal cancer accounts for up to 5% of all colo-
rectal cancers. A variety of known and unknown genes are
responsible for the two known phenotypes. Familial adenoma-
tous polyposis coli (FAP) is phenotypically characterized by
hundreds or even thousands of polyps in the colon and rectum
and by a very high incidence of colorectal cancer at young age.
FAP is caused by the tumour suppressor gene APC and is a
highly penetrant autosomal condition, while the phenotypically
similar MUTYH-associated polyposis is an autosomal recessive
disease.
The much more frequent hereditary non-polyposis colorectal
cancer syndrome (HNPCC) is caused by mutations in five mis-
match repair (MMR) genes. Although no clear-cut genotype/phe-
notype correlations in pathogenic mutations carriers of the
same MMR gene have been identified, distinct phenotypic differ-
ences are associated with mutations in different MMR genes. The
mode of inheritance of HNPCC is autosomal dominant, yet a
small but increasing number of very young patients have been
reported as carriers of biallelic MMR gene mutations. Notably,
their phenotype is different from the HNPCC phenotype and
resembles the phenotype of MMR gene knockout mice. In addi-
tion to an incomplete penetrance of about 80% for colorectal can-
cers, and susceptibility to a wide range of tumours, the age of
onset of HNPCC varies widely, ranging from 16 to 90 years. We
have identified additional genetic factors located in p53 and RNA-
SEL that influence age of disease onset in HNPCC patients carry-
ing a pathogenic MMR germline mutation.
In conclusion, mutations in a variety of genes can cause
hereditary colorectal cancer. In addition to genetic heterogeneity,
there is evidence for multiple genetic factors that contribute to
the development of disease. Identification of causative genetic
and environmental factors may contribute to a more detailed
tumour risk assessment in carriers of mutations in MMR genes.
Particularly, the knowledge of the age of onset of disease in carri-
ers of pathogenic germline mutations in MMR genes might affect
preventive strategies, including age at first surveillance, surveil-
lance intervals, and age at preventive surgery.
doi:10.1016/j.ejcsup.2006.04.044
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Activation of the epidermal growth factor receptor (EGFR) path-
way seems to be involved in the regulation of proliferation and
invasion in gastrointestinal tumors. In colon cancer increased
EGFR levels were reported in advanced and more invasive carci-
nomas. Recently EGFR-inhibitors are used as a new treatment
option in patients not responding to standard chemotherapy.
However, EGFR-signalling is dependent on the presence of var-
ious EGFR ligands and mechanisms of ligand presentation. In
addition several other mechanisms involved in the regulation
of EGFR binding have been reported (PKC, Syk, Mig6, SIRPs).
Furthermore costimulatory effects between other G-protein
coupled receptor (GPCR) were shown to increase tumor cell
proliferation.
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